National Trends and Outcomes of Acute Myocardial Infarction After Transcatheter Aortic Valve Replacement

Tanush Gupta1, Joshua Zimmer1, Rony N Lahoud1

  • 1Division of Cardiology, University of Vermont Medical Center, Burlington, Vermont, USA.

Insights

Transcatheter aortic valve replacement (TAVR) patients experiencing acute myocardial infarction (AMI) had similar revascularization rates but higher in-hospital mortality for ST-elevation MI (STEMI) compared to non-TAVR patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Background:

  • Prior studies suggest reduced invasive management for acute myocardial infarction (AMI) in patients who have undergone transcatheter aortic valve replacement (TAVR).
  • Understanding the impact of prior TAVR on subsequent AMI care and outcomes is crucial for contemporary patient management.

Purpose of the Study:

  • To investigate if a history of TAVR influences the utilization of coronary revascularization and the in-hospital outcomes of patients experiencing AMI.
  • To analyze these effects within a large, contemporary national dataset.

Main Methods:

  • A retrospective analysis of consecutive TAVR patients from 2016-2022 using the U.S. Vizient Clinical Data Base.
  • Comparison of patients with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) with or without prior TAVR.
  • Propensity score matching was employed to control for baseline patient characteristic differences.

Main Results:

  • Among 206,229 TAVR patients, STEMI occurred at 25/100,000 person-years and NSTEMI at 229/100,000 person-years.
  • Post-matching, coronary revascularization rates for STEMI (65.3% vs 63.9%) and NSTEMI (41.4% vs 41.7%) were similar between prior TAVR and no prior TAVR groups.
  • In-hospital mortality was higher for STEMI in the prior TAVR group (27.1% vs 16.7%) but lower for NSTEMI (5.8% vs 8.2%) compared to the no prior TAVR group.

Conclusions:

  • Acute myocardial infarction events following TAVR are infrequent.
  • Coronary revascularization rates for STEMI and NSTEMI do not differ between TAVR patients and the general population.
  • In-hospital mortality following STEMI is elevated in patients with a history of TAVR.
Abstract

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...